Senior Manager, Real World Evidence Analyst - Starszy Manager ds. Analityki Rzeczywistych Dowodów (Real World Evidence - RWE) at Bristol-Myers Squibb

Warsaw, Masovian Voivodeship, Poland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Master’s or PhD in Epidemiology, Biostatistics, Data Science, Health Informatics, or a related field
3+ years of experience working with real-world healthcare data (claims, EMR, registries, etc.)
2+ years of experience in pharmaceutical industry (e.g. Pharma, CRO, Biotech) and clinical trials
Proficiency in SAS, R, Python, or similar tools for data manipulation and analysis. AI/ML knowledge is a plus
Good verbal and written communication skills in English
Good understanding of industry RWD vendor database
Experience with RWD data curation, engineering, exploration, and quality control in large-scale datasets
RWD trial design and analysis experience
Ability to communicate complex real-world data concepts to non-technical stakeholders
Ability to work successfully within cross-functional teams

Responsibilities

Curate and assess the quality of real-world data (RWD) assets to ensure their suitability and understanding for intended use
Design and implement data pipelines to transform raw RWD into datasets ready for analysis
Collaborate with cross-functional teams—including Biostatistics, Data Science, HEOR, Epidemiology/Safety, Clinical, and IT—to define data requirements and analytical strategies
Conduct exploratory data analyses, identify patient cohorts, and perform data summary analytics to support real-world evidence (RWE) generation
Participate in the design of RWE studies, including the development of methodologies, data analysis, interpretation, and reporting of study results
Author or review study documents such as protocols, statistical analysis plans, study reports, publications, and study-level specifications
Develop and maintain documentation detailing data sources, transformations, and analytical methods
Ensure all work complies with data governance, privacy, and regulatory standards
Stay up to date with industry and regulatory trends, tools, and best practices in RWD/RWE analytics
Continually expand technical knowledge of statistical considerations in real-world evidence generation to ensure high-quality study design and analysis
Enhance understanding of the drug development process, as well as regulatory and commercial requirements

Skills

Key technologies and capabilities for this role

Real World EvidenceRWEReal World DataRWDHealthcare DataClaims DataEMRRegistriesData CurationData QualityData PipelinesData TransformationData AnalysisClinical TrialsEvidence Generation

Questions & Answers

Common questions about this position

What is the location for this Senior Manager role?

The position is based in Warsaw.

What is the salary range for this position?

This information is not specified in the job description.

What skills and experience are required for this role?

The role requires deep expertise in working with real-world data (RWD) such as claims, EMR, and registries, experience with RWE trials, strong analytical and communication capabilities, and a collaborative mindset.

What is the company culture like at Bristol Myers Squibb?

Bristol Myers Squibb offers a challenging, meaningful, and life-changing work environment with uniquely interesting work, opportunities to grow alongside high-achieving teams, and emphasis on balance and flexibility.

What makes a strong candidate for this RWE Analyst position?

A strong candidate has deep expertise in RWD and RWE trials, strong analytical and communication skills, a collaborative mindset, and experience curating, transforming, and analyzing complex healthcare datasets.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free